The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Amifostine-Global Market Insights and Sales Trends 2025
Synopsis
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
The global Amifostine market size is expected to reach US$ 58 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Amifostine in various end use industries. The expanding demands from the Head and Neck Cancer Adjuvant Therapy and Others, are propelling Amifostine market. 400mg/Dose, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 500mg/Dose segment is estimated at % CAGR for the next seven-year period.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Amifostine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Amifostine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Amifostine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Amifostine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Amifostine covered in this report include Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma and Mingren Pharma, etc.
The global Amifostine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Global Amifostine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Amifostine market, Segment by Type:
400mg/Dose
500mg/Dose
Global Amifostine market, by Application
Head and Neck Cancer Adjuvant Therapy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Amifostine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
The global Amifostine market size is expected to reach US$ 58 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Amifostine in various end use industries. The expanding demands from the Head and Neck Cancer Adjuvant Therapy and Others, are propelling Amifostine market. 400mg/Dose, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 500mg/Dose segment is estimated at % CAGR for the next seven-year period.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Amifostine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Amifostine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Amifostine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Amifostine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Amifostine covered in this report include Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma and Mingren Pharma, etc.
The global Amifostine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Global Amifostine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Amifostine market, Segment by Type:
400mg/Dose
500mg/Dose
Global Amifostine market, by Application
Head and Neck Cancer Adjuvant Therapy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Amifostine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Amifostine Market Overview
1.1 Amifostine Product Overview
1.2 Amifostine Market Segment by Type
1.2.1 400mg/Dose
1.2.2 500mg/Dose
1.3 Global Amifostine Market Size by Type
1.3.1 Global Amifostine Market Size Overview by Type (2018-2029)
1.3.2 Global Amifostine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Amifostine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Amifostine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Amifostine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Amifostine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Amifostine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Amifostine Sales Breakdown by Type (2018-2023)
2 Global Amifostine Market Competition by Company
2.1 Global Top Players by Amifostine Sales (2018-2023)
2.2 Global Top Players by Amifostine Revenue (2018-2023)
2.3 Global Top Players by Amifostine Price (2018-2023)
2.4 Global Top Manufacturers Amifostine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Amifostine Market Competitive Situation and Trends
2.5.1 Amifostine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Amifostine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amifostine as of 2022)
2.7 Date of Key Manufacturers Enter into Amifostine Market
2.8 Key Manufacturers Amifostine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Amifostine Status and Outlook by Region
3.1 Global Amifostine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Amifostine Historic Market Size by Region
3.2.1 Global Amifostine Sales in Volume by Region (2018-2023)
3.2.2 Global Amifostine Sales in Value by Region (2018-2023)
3.2.3 Global Amifostine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Amifostine Forecasted Market Size by Region
3.3.1 Global Amifostine Sales in Volume by Region (2024-2029)
3.3.2 Global Amifostine Sales in Value by Region (2024-2029)
3.3.3 Global Amifostine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Amifostine by Application
4.1 Amifostine Market Segment by Application
4.1.1 Head and Neck Cancer Adjuvant Therapy
4.1.2 Others
4.2 Global Amifostine Market Size by Application
4.2.1 Global Amifostine Market Size Overview by Application (2018-2029)
4.2.2 Global Amifostine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Amifostine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Amifostine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Amifostine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Amifostine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Amifostine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Amifostine Sales Breakdown by Application (2018-2023)
5 North America Amifostine by Country
5.1 North America Amifostine Historic Market Size by Country
5.1.1 North America Amifostine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Amifostine Sales in Volume by Country (2018-2023)
5.1.3 North America Amifostine Sales in Value by Country (2018-2023)
5.2 North America Amifostine Forecasted Market Size by Country
5.2.1 North America Amifostine Sales in Volume by Country (2024-2029)
5.2.2 North America Amifostine Sales in Value by Country (2024-2029)
6 Europe Amifostine by Country
6.1 Europe Amifostine Historic Market Size by Country
6.1.1 Europe Amifostine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Amifostine Sales in Volume by Country (2018-2023)
6.1.3 Europe Amifostine Sales in Value by Country (2018-2023)
6.2 Europe Amifostine Forecasted Market Size by Country
6.2.1 Europe Amifostine Sales in Volume by Country (2024-2029)
6.2.2 Europe Amifostine Sales in Value by Country (2024-2029)
7 Asia-Pacific Amifostine by Region
7.1 Asia-Pacific Amifostine Historic Market Size by Region
7.1.1 Asia-Pacific Amifostine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Amifostine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Amifostine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Amifostine Forecasted Market Size by Region
7.2.1 Asia-Pacific Amifostine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Amifostine Sales in Value by Region (2024-2029)
8 Latin America Amifostine by Country
8.1 Latin America Amifostine Historic Market Size by Country
8.1.1 Latin America Amifostine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Amifostine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Amifostine Sales in Value by Country (2018-2023)
8.2 Latin America Amifostine Forecasted Market Size by Country
8.2.1 Latin America Amifostine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Amifostine Sales in Value by Country (2024-2029)
9 Middle East and Africa Amifostine by Country
9.1 Middle East and Africa Amifostine Historic Market Size by Country
9.1.1 Middle East and Africa Amifostine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Amifostine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Amifostine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Amifostine Forecasted Market Size by Country
9.2.1 Middle East and Africa Amifostine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Amifostine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Clinigen
10.1.1 Clinigen Company Information
10.1.2 Clinigen Introduction and Business Overview
10.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Clinigen Amifostine Products Offered
10.1.5 Clinigen Recent Development
10.2 Sun Pharmaceutical
10.2.1 Sun Pharmaceutical Company Information
10.2.2 Sun Pharmaceutical Introduction and Business Overview
10.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sun Pharmaceutical Amifostine Products Offered
10.2.5 Sun Pharmaceutical Recent Development
10.3 Taj Pharmaceuticals
10.3.1 Taj Pharmaceuticals Company Information
10.3.2 Taj Pharmaceuticals Introduction and Business Overview
10.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Taj Pharmaceuticals Amifostine Products Offered
10.3.5 Taj Pharmaceuticals Recent Development
10.4 Merro Pharmaceutical
10.4.1 Merro Pharmaceutical Company Information
10.4.2 Merro Pharmaceutical Introduction and Business Overview
10.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merro Pharmaceutical Amifostine Products Offered
10.4.5 Merro Pharmaceutical Recent Development
10.5 Luye Pharma
10.5.1 Luye Pharma Company Information
10.5.2 Luye Pharma Introduction and Business Overview
10.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Luye Pharma Amifostine Products Offered
10.5.5 Luye Pharma Recent Development
10.6 Mingren Pharma
10.6.1 Mingren Pharma Company Information
10.6.2 Mingren Pharma Introduction and Business Overview
10.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mingren Pharma Amifostine Products Offered
10.6.5 Mingren Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Amifostine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Amifostine Industrial Chain Analysis
11.4 Amifostine Market Dynamics
11.4.1 Amifostine Industry Trends
11.4.2 Amifostine Market Drivers
11.4.3 Amifostine Market Challenges
11.4.4 Amifostine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Amifostine Distributors
12.3 Amifostine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
